Medanta operator Global Health raises ₹2,206 crore in India IPO

What's the deal? Global HealthDealroom has a profile for this one. Try Dealroom →, the hospital operator behind India's MedantaDealroom has a profile for this one. Try Dealroom → brand, raised ₹2,205.57 crore (about $230 million) in an initial public offering in November 2022. The book-built issue was priced at ₹319 to ₹336 per share and listed on the NSE and BSE on November 16, 2022.

How was it structured? The offer combined a ₹500 crore fresh issue with an offer for sale of up to 5.08 crore shares, worth roughly ₹1,706 crore. Selling shareholders included Anant Investments, associated with Carlyle Group, and Sunil and Suman Sachdeva.

Who backed it? Global Health raised ₹662 crore from anchor investors before the offer opened, allotting 1.97 crore shares at ₹336 each. Backers included Axis Mutual FundDealroom has a profile for this one. Try Dealroom →, HDFC Mutual FundDealroom has a profile for this one. Try Dealroom →, Aditya Birla Sun Life Mutual Fund, SBI Mutual FundDealroom has a profile for this one. Try Dealroom →, ICICI Prudential Mutual Fund, Kotak Mutual Fund, Max Life Insurance, and SBI Life Insurance.

Why now? The listing gave the company fresh capital through the primary issue while offering existing shareholders an exit route via the OFS. Anchor participation from domestic funds and insurers signalled institutional appetite ahead of the main window.

How did demand shape up? The IPO was subscribed about 9.58 times overall by the close on November 7, 2022. Demand was uneven: qualified institutional buyers bid heavily, while the retail portion stayed below one time.

The signal: The split between strong institutional interest and muted retail demand underlines how selectively investors approached healthcare listings, backing scale operators like Medanta while holding back at the individual level.

Read more: multibagg.ai

Image credit: Generated with Gemini